Exploring the potential impact of empiric antibiotic de-escalation for suspected early onset neonatal sepsis

Authors

  • Nazedah Ain Ibrahim Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia https://orcid.org/0000-0002-4490-6985
  • Mohd Makmor Bakry Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia
  • Shareena Ishak Department of Pediatrics, Faculty of Medicine Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, 56000 Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia
  • Nurul Ain Mohd Tahir Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia
  • Noraida Mohamed Shah Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia

DOI:

https://doi.org/10.3855/jidc.20654

Keywords:

neonatal, early onset sepsis, antibiotic, de-escalation

Abstract

Introduction: The aim of this study was to explore the impact of empiric antibiotic de-escalation for suspected early onset neonatal sepsis (EONS) on clinical and economic outcomes. This was a multicenter prospective cohort study. Newborns were recruited from 3 neonatal intensive care units (NICUs) in Klang Valley, Malaysia.

Methodology: All newborns in the NICU, and prescribed with empiric antibiotics within 72 hours for EONS over 4 months were included. Data on newborns’ characteristics, clinical outcomes, cost-effectiveness in 7 days, and mortality in 28 days were recorded. Antibiotic usage was divided into de-escalation and non-de-escalation groups, with 1:1 data matching for gestational age (weeks) and birth weight (± 0.1 kg). Time to treatment success, 28-days all-cause mortality, and cost-effectiveness were analyzed.

Results: A total of 687 newborns were included. Data matching was conducted for grouping into de-escalation and non-de-escalation groups (n = 262 per group) for comparative analysis. There was no significant difference in the treatment failure rate (p = 0.742) and all-cause mortality in 28-days of life (p = 0.052) between the groups. However, a significant difference in terms of time to treatment success (median 3 days in the de-escalation group vs. 5 days in the non-de-escalation group; p < 0.001)) was observed. Cost-effectiveness analysis showed cost-saving of USD 47.80 per newborn per day for the de-escalation group.

Conclusions: Early empiric antibiotic de-escalation should be considered in all newborns with a low risk of EONS. This practice did not increase the treatment failure rate and provided a beneficial outcome.

Author Biographies

Nazedah Ain Ibrahim, Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia

Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

Department of Pharmacy, Hospital Tunku Azizah, 50300 Kuala Lumpur, Ministry of Health Malaysia.

Mohd Makmor Bakry, Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia

Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

Faculty of Pharmacy, Universitas Airlangga, Indonesia

Shareena Ishak, Department of Pediatrics, Faculty of Medicine Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, 56000 Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia

Department of Pediatrics, Faculty of Medicine Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, 56000 Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia.

Nurul Ain Mohd Tahir, Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia

Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

Noraida Mohamed Shah, Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia

Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

Downloads

Published

2025-06-30

How to Cite

1.
Ain Ibrahim N, Makmor Bakry M, Ishak S, Mohd Tahir NA, Mohamed Shah N (2025) Exploring the potential impact of empiric antibiotic de-escalation for suspected early onset neonatal sepsis. J Infect Dev Ctries 19:896–903. doi: 10.3855/jidc.20654

Issue

Section

Original Articles